Company: LHI
Filing Date: 2025-08-08
Form Type: F-1/A
Source: 0001213900-25-073646
Chunk: 64

Company: Living Homeopathy International Ltd.
Filing Date: 2025-08-08
Form: F-1/A
Chunk 64
---
 of data.

Currently we do not expect the Review Measures
to have an impact on the business and operations of Living Homeopathy Hong Kong, or this offering, because (i) Living Homeopathy Hong
Kong is incorporated and operating in Hong Kong without any subsidiary or VIE structure in mainland China, and it is unclear whether
the Review Measures shall be applied to a Hong Kong company; (ii) as of the date of this prospectus, Living Homeopathy Hong Kong has
not collected and stored personal information of any individual customers of mainland China and possesses personal information of
less than one million individuals in the PRC and we have never been recognized as a critical information infrastructure operator in the
PRC; and (iii) as of the date of this prospectus, Living Homeopathy Hong Kong has not been informed by any governmental authority of
mainland China of any requirement that it file for a cybersecurity review for the offering. As of the date of this prospectus, subject
to final determination by the CAC and relevant competent authorities, Han Kun Law Offices, our PRC counsel, has advised that based
on the foregoing, Living Homeopathy Hong Kong is not required to pass the cybersecurity review of the CAC in order to list the Class
A Ordinary Shares in the U.S. Nonetheless, if the authorized PRC regulatory body subsequently determines that we are required to go through
such cybersecurity review or if any other PRC government authorities promulgate any interpretation or implementation rules before our
listing that would require us to go through a cybersecurity review for this offering, we may fail to complete such cybersecurity review
procedures in a timely manner, or at all. Any failure or delay in the completion of the cybersecurity review procedures or any other
non-compliance with the related laws and regulations may result in fines or other penalties, reputational damage as well as legal proceedings
or actions against us, which may have material adverse effect on our business, financial condition or results of operations.

<div align='center'>33</div>

In addition, on December 24, 2021, the CSRC issued the Administrative Provisions of the State Council Regarding the Overseas Issuance and Listing of Securities by Domestic Enterprises (the “Draft Administrative Provisions”) and the Measures for the Overseas Issuance of Securities and Listing Record-Filings by Domestic Enterprises (Draft for Comments) (the “Draft Filing Measures”), collectively, the Draft Rules Regarding Overseas Listings. The Draft Rules Regarding Overseas Listing aim to lay